series-a
Stage
1
Investors
About
Restera is a clinical-stage medical technology company developing a first-of-its-kind neurostimulation-based treatment for obstructive sleep apnea (OSA). The company is advancing a device therapy through clinical development aimed at delivering an alternative to existing sleep apnea treatments.
Explore Restera's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.